PRE 14A

PROXY STATEMENT

Company: TENAX THERAPEUTICS, INC.
Filed: July 31, 2014
Period of Report: September 11, 2014
Accession Number: 0001354488-14-003807

View Document ↗ View on SEC.gov ↗